Answers are grounded in this paper and cite their sources.
Background and Objectives: Weight-based heparin dosing before cardiopulmonary bypass (CPB) does not always achieve the target activated clotting time (ACT), and reported rates depend on the dose and threshold used. We aimed to identify routine preoperative laboratory values associated with an inadequate initial ACT response and to describe its definition-dependent frequency. Materials and Methods: At a tertiary center in Türkiye, this retrospective available-record cohort cross-referenced routine perfusion records with hospital information-system data at the person level for 638 adults undergoing cardiac surgery with CPB in 2023–2024 under a 300 IU/kg initial heparin protocol; this non-consecutive cohort represented 30.0% (638/2127) of CPB operations. The primary outcome was an arterial-blood ACT below 450 s measured 3 min after central venous administration of the initial dose; four alternative definitions were compared. Results: The primary outcome occurred in 176 patients (27.6%; 95% CI, 24.3–31.2%), and the proportion ranged from 14.1% (ACT below 400 s) to 43.6% (ACT below 480 s) across the five definitions. The prespecified 12-variable model was not statistically significant as a whole (likelihood-ratio p = 0.135), had poor discrimination (optimism-corrected area under the curve (AUC), 0.550), and identified no reliable routine predictor. Within this non-significant model, the C-reactive protein coefficient was nominally significant (adjusted odds ratio per 5 mg/L, 1.06; 95% CI, 1.01–1.12) and is hypothesis-generating only. The neutrophil-to-lymphocyte, platelet-to-lymphocyte, and systemic immune-inflammation indices did not discriminate (AUC, 0.510–0.531). In post hoc exploratory analyses, the 12-variable model for an ACT below 400 s was statistically significant (p = 0.034) but discriminated poorly (optimism-corrected AUC, 0.596), and weighting the cohort to all CPB operations by calendar quarter and type of surgery gave a similar frequency of the primary outcome (27.9%; 95% CI, 23.9–31.8%). Conclusions: An arterial-blood ACT below 450 s 3 min after central venous administration of 300 IU/kg was common in this available-record cohort, and its frequency varied more than threefold with the definition used. No routine preoperative variable evaluated, including C-reactive protein and the blood count-derived indices, was a reliable predictor or provided clinically useful discrimination before surgery.
No takes yet. Share an insight, caveat, or question.
Aytünür et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: